Table 6.
Estimates of the incidence rate of different pneumococcal diseases in Latin America and the Caribbean and S. pneumoniae19A specific incidence
| Range expressed in cases per 100,000/year | ||||
|---|---|---|---|---|
|
Condition |
Age group (years) |
|||
| |
<1 |
<2 |
<3 |
<5 |
| Invasive pneumococcal disease IPD |
61 (58–63)a |
61 (52–71) |
|
32 (32–33) |
|
S. pneumoniae 19A specific incidenceb |
2.3 (2.2–2.9) |
2.8 (2.4–3.3) |
|
|
| Pneumococcal meningitis |
19 |
12 |
|
11 (9–15) |
|
S. pneumoniae 19A specific incidencec |
0.6 |
0.4 |
|
0.3 (0.27–0.45) |
| Pneumococcal pneumonia |
|
51 (47–55) |
|
34 |
|
S. pneumoniae 19A specific incidenced |
|
1.98 (1.8–2.1) |
|
1.3 |
| Pneumococcal sepsis |
|
12 |
|
|
|
S. pneumoniae 19A specific incidencee |
|
0.6 |
|
|
| Pneumococcal bacteremia |
|
|
2 |
|
| S. pneumoniae 19A specific incidence4 | 0.2 | |||
(Adapted from reference [62]).
a (25th–75th percentile, when reported).
bS. pneumoniae 19A distribution reported in SIREVA 1993–2009 = 3.8%.
cS. pneumoniae 19A distribution reported in SIREVA 2000–2009 = 3.0%.
dS. pneumoniae 19A distribution reported in SIREVA 2006–2007 = 3.9%.
eS. pneumoniae 19A distribution reported in SIREVA 2000–2009 = 4.6%.